Related Experiment Video

Updated: Jun 6, 2025

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

3.0K

eEF2K as an important kinase associated with cancer survival and prognosis

Nan Wang1,2,3, Li-Lan Cen4,5, Zhe Tian6

  • 1The Second Surgical Department of Breast Cancer, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, 30071, China.

Scientific Reports
|November 26, 2024
PubMed

Insights

Eukaryotic Elongation Factor 2 Kinase (eEF2K) plays a dual role in cancer, affecting protein synthesis and patient prognosis. Targeting eEF2K and its phosphorylation may offer new cancer treatment strategies.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Biochemistry

Background:

  • Eukaryotic Elongation Factor 2 Kinase (eEF2K) regulates protein synthesis, especially during cellular stress.
  • eEF2K is a member of the α-kinase family.
  • Its role in cancer progression is complex and warrants further investigation.

Purpose of the Study:

  • To conduct a pan-cancer analysis of eEF2K expression, genetic variants, and clinical relevance.
  • To investigate the role of eEF2K and eEF2 phosphorylation in cancer biology.
  • To explore potential therapeutic strategies targeting eEF2K.

Main Methods:

  • Utilized data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) for pan-cancer analysis.
  • Examined eEF2K expression, genetic variants, and correlation with patient prognosis.
  • Investigated eEF2 phosphorylation sites (T57, Y434, T59) and potential alternative regulatory kinases.

Main Results:

  • eEF2K exhibits dual roles in cancer progression, with expression levels correlating with patient prognosis.
  • Significant eEF2 phosphorylation at T57, Y434, and T59 was observed, potentially regulating protein synthesis under stress.
  • Elevated T59 phosphorylation in colorectal adenocarcinoma (COAD) despite low eEF2K expression suggests alternative kinase regulation (e.g., AMPK, mTOR).
  • eEF2K participates in peptidyl-serine phosphorylation, G2/M transition, and the MAPK cascade.
  • eEF2K protein localizes to the nucleus, cytoplasm, and cytosol, interacting with ATP and calcium ions.

Conclusions:

  • eEF2K has a complex role in cancer, influencing protein synthesis and patient outcomes.
  • Alternative kinases may compensate for low eEF2K expression in regulating eEF2 phosphorylation.
  • Targeting eEF2K and eEF2 phosphorylation presents a promising avenue for novel cancer therapeutics.
Keywords:
CancerPan-cancer analysisPhosphorylationPrognosiseEF2K

More Related Videos

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

7.3K
Assaying Protein Kinase Activity with Radiolabeled ATP08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

18.3K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.7K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K